Tag: drug safety

Latest articles

NICE recommends new treatment for asthma in the UK

NICE recommends new treatment for asthma in the UK

The National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination (FAD) recommending Dupixent® (dupilumab), as an add-on maintenance treatment...
Entries for the Pf Awards 2022 are officially open

Enter today! The Pf Awards 2022 are officially open

New Year | New Suite of Categories | New Candidates Would you like to be recognised as a top performer in the UK Pharmaceutical industry? Enter...
New study to explore if talazoparib could treat metastatic breast cancer

New study to explore if talazoparib could treat metastatic breast cancer

A new study funded by Breast Cancer Now will explore if the drug talazoparib (Talzenna) could be used to treat people with incurable secondary...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Adapting for success: Understanding commercial optimisation

Adapting for success: Understanding commercial optimisation

How do you best align your field force with the changing landscape within the NHS? Oli Hudson, Content Director at Wilmington Healthcare, outlines the...
NICE recommends new treatment for asthma in the UK

NICE recommends new treatment for asthma in the UK

The National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination (FAD) recommending Dupixent® (dupilumab), as an add-on maintenance treatment...

Pancreatic Cancer Story: James Dadge

James, 44, lives in Manchester with his partner Andrea and sons Ben and Daniel. He was diagnosed with a neuroendocrine tumour, with the primary...
Positive SMC decision for first long-acting injectable HIV treatment

Positive SMC decision for first long-acting injectable HIV treatment

ViiV Healthcare has announced that the Scottish Medicines Consortium (SMC) has accepted Vocabria▼ (cabotegravir long-acting injection) in combination with Rekambys▼ (rilpivirine long-acting injection) for...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription